Buscar resultados de ensayos clínicos
Blepharitis - 25 Studies Found
Estado | Estudiar |
Completed |
Nombre del estudio: Safety and Efficacy Pilot Study of AzaSite® for Four Weeks in Subjects With Blepharitis Condición: Blepharitis Fecha: 2008-04-07 Intervenciones: Drug: AzaSite® Ophthalmic solution; 1 drop in each eye BID for two days, then 1 drop in each eye QD |
Terminated |
Nombre del estudio: A Four Week Study of Azithromycin Ophthalmic Solution, 1% Versus Vehicle in Subjects With Blepharitis (P08636) Condición: Blepharitis Fecha: 2010-12-21 Intervenciones:
|
Completed |
Nombre del estudio: Efficacy and Safety Study of a Steroid/Antibiotic Combination Eyedrop to Treat Non-Bacterial Blepharitis Condición: Blepharitis Fecha: 2011-08-01 Intervenciones:
|
Completed |
Nombre del estudio: Topical IL-1-Ra for Treatment of Posterior Blepharitis Condición: Posterior Blepharitis Fecha: 2008-05-19 Intervenciones:
|
Completed |
Nombre del estudio: A Study to Evaluate the Clinical Efficacy and Safety of Tobradex® ST Compared to Azasite® in the Treatment of Subjects With Moderate to Severe Chronic Blepharitis Condición: Blepharitis Fecha: 2010-04-09 Intervenciones:
|
Completed |
Nombre del estudio: Treatment of Demodex Blepharitis With Ivermectin Gel 0.1% Plus Metronidazole 1% Condición: Chronic Blepharitis Fecha: 2014-09-08 Intervenciones: Drug: Ivermectin 0.1% Metronidazole 1% Other Name: 22,23-dihydroavermectin B1a + 22,23-dihydroavermectin |
Completed |
Nombre del estudio: Efficacy and Safety of Posiformin 2 % Eye Ointment in the Treatment of Blepharitis Condición:
Fecha: 2011-05-18 Intervenciones:
|
Completed |
Nombre del estudio: Demodex Blepharitis Treatment Study Condición: Chronic Blepharitis Fecha: 2012-07-12 Intervenciones:
|
Completed |
Nombre del estudio: The Effects of Azithromycin Ophthalmic Solution, 1% Versus Placebo in Subjects With Blepharitis During a Two-Week Treatment Period Condición: Blepharitis Fecha: 2009-05-01 Intervenciones:
|
Completed |
Nombre del estudio: The Effects of Azithromycin Ophthalmic Solution, 1% Versus Placebo in Subjects With Blepharitis During a Four-Week Treatment Period (P08638) Condición: Blepharitis Fecha: 2009-05-05 Intervenciones:
|